Inflammation still ravages the lungs of some smokers years after they quit the habit. What sparks that smoldering destruction remained a mystery until a consortium of researchers led by Baylor College of Medicine found that certain dendritic cells in the lung - the cells that “present” a foreign antigen or protein to the immune system - provoke production of destructive T-cells that attack a key protein called elastin, leading to death of lung tissue and emphysema.
Lees meer..

New research reveals a pathway that links peripheral sensory tissues with a “clock” in the brain to regulate molecular processes and behaviors in response to cyclical temperature changes. The research, published by Cell Press in the October 29th issue of the journal Neuron, reveals some surprising fundamental differences between how light-dark and temperature cycles synchronize the brain clock of the fruit fly, Drosophila.
Lees meer..

New research finds that adult neurons can still regenerate as long as 15 months after a spinal cord injury. The study, published by Cell Press in the October 29th issue of the journal Neuron, highlights the success of a strategy that targets multiple environmental and intrinsic obstacles known to limit nervous system plasticity and regeneration.
Lees meer..

Many of nature’s most fascinating phenomena involve forms of fluid flow - the motions of liquids and gases - from the flight of golf and tennis balls to the slip of a red blood cell, the flap of an elephant ear, the line of a wildfire, the spin of a storm, or the formation of a crater on the Moon. The 62nd Annual Meeting of the American Physical Society’s (APS) Division of Fluid Dynamics takes place from November 22-24 at the Minneapolis Convention Center.
Lees meer..

Scientists in California are reporting development of a new generation of the microcapsules used in carbon-free copy paper, in which capsules burst and release ink with pressure from a pen. The new microcapsules burst when exposed to light, releasing their contents in ways that could have wide-ranging commercial uses from home and personal care to medicine.Their study appears in the Journal of the American Chemical Society, a weekly publication.
Lees meer..

An expert in cancer proteomics at Fred Hutchinson Cancer Research Center has received $4.8 million in federal stimulus funding from the National Cancer Institute to co-lead a pilot study to assess the feasibility and scalability of a project that aims to measure all of the proteins in the human body. “If successful, this study could help to stimulate a larger international endeavor that would be comparable to the Human Genome Project,” said Amanda Paulovich, M.D., Ph.D.
Lees meer..

Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter Plc announced positive top-line results from a Phase IIb clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of acute exacerbation of schizophrenia.
Lees meer..

Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL - News), launched a newly designed, patient-friendly EpiPen® Auto-Injector 0.3/0.15 mg. This next-generation EpiPen Auto-Injector maintains the simplicity, speed, safety and reliability of EpiPen Auto-Injector with several new, user-friendly features, including being the only auto-injector with needle-protection before and after use. Dey President Carolyn Myers, Ph.D.
Lees meer..

Nektar Therapeutics (Nasdaq: NKTR) announced that it has completed enrollment ahead of schedule in its Phase 2 clinical study of NKTR-102 in platinum-resistant ovarian cancer. NKTR-102 is Nektar’s investigational proprietary compound currently being evaluated in Phase 2 clinical development in ovarian, breast and colorectal cancers.
Lees meer..

ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce that they have completed recruitment of their Phase II trial of TB-402 ahead of schedule. TB-402 is a novel, long acting anticoagulant that is being developed for the prevention of deep vein thrombosis (DVT) following orthopaedic surgery. The results of this study, which has recruited 315 patients, are anticipated in the second quarter of 2010.
Lees meer..